SCOTTS MIRACLE-GRO CO (SMG) Forecast, Price Target & Analyst Ratings
NYSE:SMG • US8101861065
68.84 USD
-0.66 (-0.95%)
Last: Mar 4, 2026, 11:27 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCOTTS MIRACLE-GRO CO (SMG).
Forecast Snapshot
Consensus Price Target
$74.66
+ 8.46% Upside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ2 / 2026
EPS Estimate$4.02
Revenue Estimate1.418B
ChartMill Buy Consensus
81.82%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$74.66
Upside
+ 8.46%
From current price of $68.84 to mean target of $74.66, Based on 11 analyst forecasts
Low
$67.67
Median
$73.44
High
$86.10
Price Target Revisions
1 Month
1.20%
3 Months
1.20%
Price Target Summary
11 analysts have analysed SMG and the average price target is 74.66 USD. This implies a price increase of 8.46% is expected in the next year compared to the current price of 68.84.
The average price target has been revised upward by 1.2% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.82%
SMG was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SMG.
In the previous month the buy percentage consensus was at a similar level.
SMG was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Stifel | Maintains | Buy -> Buy |
| 2026-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | Stifel | Upgrade | Hold -> Buy |
| 2025-11-05 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Stifel | Maintains | Hold -> Hold |
| 2025-07-31 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-09 | Stifel | Downgrade | Buy -> Hold |
| 2025-06-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-06 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-01 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-07 | Jefferies | Upgrade | Hold -> Buy |
| 2025-04-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-02 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-03-04 | Stifel | Upgrade | Hold -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ2 / 2026
EPS Estimate$4.02
Revenue Estimate1.418B
Revenue Q2Q-0.21%
EPS Q2Q1.03%
Number of Analysts8
Next Earnings Revisions
Revenue (1 Month)
-1.87%
Revenue (3 Months)
-1.87%
EPS (1 Month)
-0.53%
EPS (3 Months)
-0.52%
Next Earnings Summary
SMG is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 4.02 USD and the consensus revenue estimate is 1.42B USD.
The next earnings revenue estimate has been revised downward by 1.87% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.551B -9.50% | 3.553B 0.04% | 3.413B -3.93% | 3.344B -2.02% | 3.423B 2.36% | 3.49B 1.96% | 3.649B 4.56% | 3.774B 3.43% | 3.903B 3.42% | 4.035B 3.38% | 4.17B 3.35% | |
| EBITDA YoY % growth | 384.3M -26.72% | 435.7M 13.37% | 517.3M 18.73% | 600.84M 16.15% | 639.9M 6.50% | 677.34M 5.85% | 702.76M 3.75% | 746.69M 6.25% | 792.55M 6.14% | 840.42M 6.04% | 890.42M 5.95% | |
| EBIT YoY % growth | 291.8M -30.39% | 355.1M 21.69% | 442.3M 24.56% | 484.37M 9.51% | 520.43M 7.44% | 544.61M 4.65% | 529.44M -2.79% | 567.42M 7.17% | 607.11M 6.99% | 648.72M 6.85% | 692.25M 6.71% | |
| Operating Margin | 8.22% | 10.00% | 12.96% | 14.48% | 15.20% | 15.60% | 14.51% | 15.03% | 15.55% | 16.08% | 16.60% | |
| EPS YoY % growth | 1.16 -71.64% | 2.24 93.10% | 3.72 66.07% | 4.33 16.53% | 4.92 13.39% | 5.33 8.45% | 5.80 8.76% | 6.58 13.41% | 7.42 12.90% | 8.35 12.52% | 9.35 11.97% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.02 1.03% | 2.87 10.89% | -1.75 10.64% | -0.85 -10.14% | 4.34 7.91% | 3.18 10.89% | -1.62 7.74% | -0.80 5.92% | 5.18 19.40% | 3.68 15.43% | -1.83 -13.12% |
| Revenue Q2Q % growth | 1.418B -0.21% | 1.224B 3.03% | 381.29M -1.58% | 367.19M 3.61% | 1.473B 3.88% | 1.299B 6.13% | 389.88M 2.25% | 355.24M -3.25% | 1.515B 2.85% | 1.321B 1.69% | 393.69M 0.98% |
| EBITDA Q2Q % growth | 398.21M -0.60% | 280.44M 1.02% | -80.186M -116.13% | -5.353M -1,684.33% | 427.17M 7.27% | 309.75M 10.45% | -73.003M 8.96% | 2.596M 148.50% | 461.33M 8.00% | 311.79M 0.66% | -79.265M -8.58% |
| EBIT Q2Q % growth | 367.62M 1.36% | 245.29M 10.94% | -108.372M 3.33% | -31.086M -66.23% | 400.08M 8.83% | 276.58M 12.76% | -97.744M 9.81% | -21.362M 31.28% | 437.57M 9.37% | 288.2M 4.20% | -102.626M -5.00% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
12.74%
EPS Next 5 Year
12.07%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
0.44%
Revenue Next 5 Year
1.85%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
15.53%
EBIT Next 5 Year
11.19%
SCOTTS MIRACLE-GRO CO / SMG Forecast FAQ
What is the price target for SMG stock?
11 analysts have analysed SMG and the average price target is 74.66 USD. This implies a price increase of 8.46% is expected in the next year compared to the current price of 68.84.
What is the next earnings date for SMG stock?
SCOTTS MIRACLE-GRO CO (SMG) will report earnings on 2026-04-29, before the market open.
Can you provide the consensus estimates for SCOTTS MIRACLE-GRO CO next earnings?
The consensus EPS estimate for the next earnings of SCOTTS MIRACLE-GRO CO (SMG) is 4.02 USD and the consensus revenue estimate is 1.42B USD.
What is the number of analysts for SMG stock?
The number of analysts covering SCOTTS MIRACLE-GRO CO (SMG) is 11.